Tate & Lyle receives innovation in health technology product award | Tate & Lyle

Tate & Lyle receives innovation in health technology product award

| Filed in:

Award recognises Tate & Lyle's leadership in precision prebiotic technologies and evidence-based nutritional research.

Shanghai, China 25 June 2026 - Tate & Lyle PLC (Tate & Lyle), a global leader in ingredient solutions for healthier food and beverages, is delighted to announce that it has received the Innovation in Health Technology Product Award at the Boao Food for Health Science Conference and Expo (FHE) 2026, recognising its leadership in precision prebiotic technologies and evidence-based nutritional research.

The award celebrates innovations that demonstrate meaningful scientific advancement, strong validation, and the ability to deliver measurable health benefits in real-world food and beverage applications.

At the event in Boao, Hainan, China, Tate & Lyle showcased its portfolio of functional oligosaccharide dietary fibres and prebiotic solutions. This includes EUOLIGO® FOS, GOSYAN® GOS, PROMITOR® Soluble Fibre and STA-LITE® Polydextrose – forming a comprehensive and scalable fibre portfolio designed to support gut health and enable product innovation across a wide range of food and beverage applications.

The breadth and value of Tate & Lyle’s comprehensive fibre portfolio is underpinned by an integrated research framework and application expertise, enabling customers to translate scientific insight into commercially viable products. Together, these capabilities support the development of solutions that are grounded in robust science and designed to perform in real-world conditions.

Commenting on the award, Remington Zhu, President, Asia Pacific at Tate & Lyle, said: “This award recognises our scientific capabilities and our continued focus on advancing prebiotic innovation. Our approach is centred on translating scientific research into practical solutions that support health while meeting the expectations of both customers and consumers.

“As demand for functional ingredients continues to grow, we remain focused on delivering solutions that are scientifically robust, scalable, and designed to work across a wide range of applications.”

This recognition reflects Tate & Lyle’s research capabilities and reinforces its role in advancing science-led innovation across the food and health industry.

ENDS

For media enquiries, contact: [email protected]

Click here for our press image gallery

About Tate & Lyle PLC:  

Supported by over 165-years of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients and solutions every day.  

Through our leading expertise in sweetening, mouthfeel and fortification, we develop ingredients and solutions which reduce sugar, calories and fat, add fibre and protein, and provide texture and stability to food and drink in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.   

Tate & Lyle has approximately 5,000 employees working in around 70 locations in 37 countries, serving customers in more than 120 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives through the Science of Food. By living our purpose, we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.  

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. For the year ended 31 March 2026 Tate & Lyle revenue from continuing operations totalled £2.0 billion. For more information, please visit www.tateandlyle.com or follow Tate & Lyle on LinkedIn, X (Twitter), Facebook or YouTube